why choose us

First received: June 29, 2023

Clinical Trial: A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Emraclidine

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hepatic Impairment

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-label Trial to Evaluate the Pharmacokinetics and Safety Following a Single Dose of Emraclidine in Adult Participants With Mild, Moderate, and Severe Hepatic Impairment Compared With Ad

Brief Summary: The primary purpose of this study is to assess the effect of hepatic impairment on the pharmacokinetics (PK) of emraclidine following administration of a single oral dose in participants with mild, moderate, and severe hepatic impairment relative to matched participants with normal hepatic function.

Read more